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Abstract
Background: Our goal was to determine whether short-term intermittent hypoxia exposure, at
a level well tolerated by healthy humans and previously shown by our group to increase EPO and
erythropoiesis, could mobilize hematopoietic stem cells (HSC) and increase their presence in
peripheral circulation.
Methods: Four healthy male subjects were subjected to three different protocols: one with only
a hypoxic stimulus (OH), another with a hypoxic stimulus plus muscle electrostimulation (HME)
and the third with only muscle electrostimulation (OME). Intermittent hypobaric hypoxia exposure
consisted of only three sessions of three hours at barometric pressure 540 hPa (equivalent to an
altitude of 5000 m) for three consecutive days, whereas muscular electrostimulation was
performed in two separate periods of 25 min in each session. Blood samples were obtained from
an antecubital vein on three consecutive days immediately before the experiment and 24 h, 48 h,
4 days and 7 days after the last day of hypoxic exposure.
Results: There was a clear increase in the number of circulating CD34+ cells after combined
hypobaric hypoxia and muscular electrostimulation. This response was not observed after the
isolated application of the same stimuli.
Conclusion: Our results open a new application field for hypobaric systems as a way to increase
efficiency in peripheral HSC collection.
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Background
Stem cells (SCs) are primitive cells with the potential to
differentiate into mature cells [1]. An increase in SCs is
observed after various events such as myocardial infarc-
tion [2], dilated myocardiopathy [3], cardiac surgery with
cardiopulmonary bypass [4], twelve weeks of physical
exercise [5,6], menstruation [7], cessation of smoking [8],
and in animals or human cells subjected to deep hypoxia
conditions in vitro [9-12].
Several studies have found that elevated concentrations of
SCs correlate with better clinical outcomes [13], since they
possess a general regenerative capacity in blood vessel dis-
orders [14]. Various methods of SC delivery have been
shown to be beneficial, mostly with autologous bone
marrow cell transplantation [15-17]. No significant differ-
ences were found when bone marrow cells or SCs from
peripheral blood were compared [18], nor when the com-
parison was made between bone marrow cells and adi-
pose tissue-derived SCs [19].
An EPO-induced increase of hematopoietic stem cells
(HSCs) has been detected in healthy individuals and in
patients with renal anemia at two weeks post-administra-
tion [20]. Moreover, an EPO-induced mobilization and
homing of HSCs and their mediated neovascularization
has also been reported in rats after post-myocardial infarc-
tion heart failure after six weeks of treatment [21].
Historically, intermittent hypoxia exposure sessions have
been used to improve the physical condition and to treat
several illnesses, mostly in the countries of the former
Soviet Union, although this has been done without a clear
understanding of their holistic effects [22]. At all events,
this practice has now become widespread in the sport
world, and there are even several commercialized forms.
Hypoxia exposure has been combined with normal ath-
letic training according to different patterns [23], the most
widely-adopted at present being the living-high training-
low model [24].
The different forms of standard physical exercise can be
difficult to apply with hypoxic procedures, especially in
some patients with severe obesity, osteoarticular condi-
tions, neurological sequelae, etc. In contrast, muscle elec-
trostimulation can be easier to apply and has been shown
to be as efficient in mimetizing training effects [25-27].
However, intermittent hypobaric hypoxia exposure has
been demonstrated to be an efficient stimulus for eliciting
adaptive responses in myocardium [28] and skeletal mus-
cle [29].
The aim of the present study was to determine whether it
was possible to increase blood SC concentration by means
of: 1) short-term intermittent hypoxia, at levels well toler-
ated by healthy humans and previously demonstrated by
our group as being capable of increasing EPO and stimu-
late erythropoiesis [30] and 2) muscular electrostimula-




Subjects were four healthy males, all members of the
research group (AR, CJ, GV and JLV), without toxic habits
or medication and with different levels of habitual physical
activity (one jogger 4 days/week, one gym user, also 4 days/
week, and two without regular physical training). Their
mean age was 54.3 (range 46-60), mean height 175 cm
(range 170-182), and mean body mass 85.5 kg (range 75-
89). They were each subjected to three different protocols:
one with only a hypoxic stimulus (OH), another with a
hypoxic stimulus plus muscle electrostimulation (HME)
and the third with only muscle electrostimulation (OME)
[see additional file 1]. In order to avoid undesired interac-
tions, each experimental set was performed at least three
months after the preceding one. A hypobaric hypoxia stim-
ulus was applied in a computer-controlled hypobaric
chamber [see additional file 2] (CHEx-1; Moelco, Spain)
for 3 h on three consecutive days, always from 5 to 8 a.m.
(subjects having spent the previous week following the
habitual diet and physical activity and with no detected ill-
nesses or chronobiologic changes); the simulated altitude
was 5000 m (400 mmHg = 533 hPa), reached in 10 min
and returning to sea level pressure in 15 min.
Muscle electrostimulation was applied by means of a Win-
form Stimulation System (Model W5 multi frequency
training, Winform S.r.l., Venice, Italy) according to a
widely accepted procedure and following previously
described general characteristics [31]. Surface electrodes
were fixed on both knee extensors and abdominal wall
muscles. Stimulation was achieved at the maximal toler-
ated intensity (regulated individually by each experimen-
tal subject) during two periods of 25 min, one in the first-
half period of hypobaric chamber stay (90 min) and the
other in the second 90-min period of stay. The protocol of
OME was the same as HME and also took place into the
hypobaric chamber; however, as the door was open there
was no hypoxic stimulus. Oxygen arterial saturation was
measured at rest during each hypoxia exposure session by
means of a pulsioxymeter (Onyx II 9550, Nonin Medical
Inc., Plymouth, MN). The study was conducted according
to the Helsinki Declaration and the experimental protocol
was approved by the institutional ethics committee.
Blood sampling, CD34 staining and flow cytometry assay
In order to detect possible individual oscillations, base-
line blood samples were drawn on each of the three days
prior to the first experiment (OH). Subsequently, blood
samples were always obtained just before each of the
experimental sets (OH, HME and OME) and 24 h, 48 h, 4Journal of Translational Medicine 2009, 7:91 http://www.translational-medicine.com/content/7/1/91
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and 7 days later. In the third protocol (OME) an addi-
tional sample was taken 10 days after the end of muscular
electrostimulation. All samples were obtained between 6
and 8 a.m. following the same extraction methodology as
detailed below. Samples were preserved, without any pre-
vious processing, at a temperature between 4 and 6°C
until transfer to the hematology laboratory. There they
were processed according to a blinded design (the techni-
cians involved had no knowledge of either the experimen-
tal subject or the protocol).
Peripheral blood samples were collected by puncture of
an antecubital vein and placed in tubes treated with 0.34
M di-potassium ethylenediaminetetraacetic acid anticoag-
ulant. All samples were stored at a temperature of 4°C and
processed within 24 h of arrival at the laboratory. Blood
cell count was assessed by use of an automatic cell counter
(AcT-diff; Beckman Coulter, Miami, FL). Samples were
incubated for cytometric absolute count with anti-human
fluorescein isothiocyanate (FITC)-conjugated CD45 mon-
oclonal antibody (Beckman Coulter, clone J.33) and anti-
human phycoerythrin (PE)-conjugated anti-CD34 (clone
8G12, Becton Dickinson) in PBS containing 1% albumin
and 0.1% sodium azide for 15 min at room temperature.
Red blood cells were lysed with 1 ml of quick lysis solu-
tion (CYT-QL-1, Cytognos) for 15 min at room tempera-
ture. Samples were incubated under dark conditions and
analyzed immediately. To ensure accuracy, reverse pipet-
ting was used to dispense the volumes.
A single-platform protocol with Perfect-Count micro-
spheres CYT-PCM-50 (Cytognos, Salamanca, Spain) was
used according to manufacturer's instructions. The Per-
fect-Count microspheres system contains two different
fluorospheres in a known proportion (A and B beads),
thus assuring the accuracy of the assay by verifying the
proportion of both types of beads. Known volumes (25
μl) of Perfect-Count Microspheres were added to the same
known volume (25 μl) of stained blood in a lyse-no-wash
technique, and the beads were counted along with the
cells. Cell viability was measured by staining the samples
with the vital dye 7-aminoactinomycin D (7-AAD), as
proposed by the ISHAGE guidelines [32]. Samples were
analyzed on a FACScan Scalibur flow cytometer (BD Bio-
sciences) with a 488-nm argon laser and Cell Quest 3.1
software (BD Biosciences). The instrument was aligned
and calibrated daily using a three-color mixture of Cal-
ibrite™ beads (BD Biosciences) with FACSComp software
(BD Biosciences). The gating strategy followed also
ISHAGE guidelines [32].
Statistical analyses
The non-parametric Friedman test for repeated measures
was used. All tests were performed using SPSS v.14. Statis-
tical significance was set at P < 0.05. Values are expressed
as the median value ± standard deviation (SD).
Results
Only the HME experimental data set showed a clear
increase for all the subjects (about 3× fold) in the percent-
age of circulating CD34+ cells, although no significant dif-
ferences were detected (p = 0.056). However, the number
of circulating CD34+ cells increased in this experiment
from a median value of 0.95 cells·μL-1 (range: 0.5-2.1) to
reach a median level of 6.65 cells·μL-1 (range: 3.7-10.7),
this increase being clearly significant (p = 0.009) (Figure
1).
No other studied parameter showed changes in this exper-
imental block. Furthermore, neither OH nor OME experi-
mental data showed statistically significant changes across
the study for general leukocyte parameters or circulating
CD34+ cells (Table 1).
Discussion
The main result of the present study is the synergic capac-
ity of a short-term intermittent hypoxic stimulus plus sur-
face-electrode muscle electrostimulation to increase the
circulating concentrations of hematopoietic CD34+ stem
cells in a group of four healthy men aged around 50 years
old. This increase can be considered as substantial,
because it is generally accepted that a concentration of 7
cells/μL is equivalent to approximately 5·105 cells·kg-1 in
an adult subject. This concentration can be assumed to be
useful for harvesting purposes and corresponds to a con-
siderable fraction of the increase in CD34+ cells obtained
after a standard five-day treatment involving two-day
doses of G-CSF (personal data).
CD34+ cells after hypobaric hypoxia and muscle electrostim- ulation Figure 1
CD34+ cells after hypobaric hypoxia and muscle elec-
trostimulation. Evolution of the CD34+ cell count (left 
axis; red bars) and percentage (right axis; blue circles) during 
the HME experimental set. Category medians and positive 
standard errors are shown for the two variables. A statisti-
cally significant increase for CD34+ concentration (cells/μL) 
was found (p = 0.009).Journal of Translational Medicine 2009, 7:91 http://www.translational-medicine.com/content/7/1/91
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It also seems that the increases in CD34+ produced by G-
CSF have a non-progressive tendency, as reported in a
study of patients with myocardial infarction, in whom cir-
culating CD34+ levels began to decrease the day after the
fourth consecutive dose of G-CSF, reaching the previous
concentrations between days 6 and 10 after the end of G-
CSF treatment [33]. In the present study, CD34+ levels
appear to continue increasing 7 days after the last hypoxia
session, and thus it is not clear if a plateau or maximum
value has been reached. It should also be taken into
account that G-CSF shows some pro-thrombotic
effects[34,35].
The lack of response in the OHE experiment does not
seem attributable to the age of the study participants,
since a clear HSC response to physical exercise was
detected in a group of 63-year-old men [6]. However,
there are alternative explanations for these findings: 1) the
relatively short duration of the hypoxic stimulus (a total
of 9 h), whereas positive neurogenesis in rats was demon-
strated after applying a hypoxic stimulus of 4 h per day
over two weeks [9], while other studies detected a positive
SC response to physical exercise after about three months
of routine physical activity [5,6]; at all events 7 days are
enough after myocardial infarction to increase the
number of CD34+ cells [36] and a single intense exercise
test is able to increase HSC 24-48 h after an exercise bout
[37,38]; or 2) the low intensity of the stimulus in our
study (used in order to be applied and tolerable to a large
majority of healthy people) compared with some in vitro
studies, in which clearly more hypoxic atmospheres were
used [10,11]. Obviously, a higher number of repeated
hypoxia sessions could be applied; however, it does not
seem reasonable to use much more intense (higher simu-
Table 1: Leukocyte parameters in the three experimental sets
Before IHH After 3 days of IHH
Sampling days -2 -1 0 1 2 4 7 10
Total leukocyte count OH 6.4 7.2 7.1 6.7 7.6 7.1 6.6
1.10 1.25 1.51 1.53 1.72 1.30 1.32
HME 7.2 7.0 6.8 6.7 6.9
1.93 2.36 0.54 1.33 1.31
OME 6.2 6.9 7.6 6.9 8.7 7.8
2.86 0.45 0.71 1.86 1.25 1.17
% Lymphocytes OH 31.9 31.6 29.4 28.3 30.0 29.2 33.3
5.00 4.88 6.68 7.01 6.65 6.88 6.03
HME 40.0 27.9 32.4 47.1 35.7
7.50 7.29 5.39 10.53 6.24
OME 43.2 36.2 31.7 27.5 31.7 34.7
5.40 2.80 5.61 7.14 8.88 6.14
% MNC OH 43.2 44.2 40.4 37.4 41.0 41.0 42.3
3.80 3.04 7.08 7.78 8.53 7.75 6.44
HME 40.5 30.0 42.9 33.7 30.6
7.67 8.74 7.46 7.18 6.06
OME 42.7 38.2 34.3 41.6 44.1 43.3
4.20 3.02 5.31 7.40 10.03 6.71
% CD34+ OH 0.081 0.050 0.064 0.063 0.061 0.050 0.075
0.006 0.040 0.014 0.017 0.012 0.026 0.023
HME 0.025 0.040 0.050 0.070 0.100
0.017 0.008 0.019 0.036 0.030
OME 0.050 0.040 0.055 0.035 0.045 0.045
0.013 0.010 0.017 0.019 0.024 0.028
CD34+/L OH 4.60 3.20 4.55 4.04 4.20 3.95 5.35
0.81 3.36 1.92 1.18 1.14 2.09 1.93
HME 0.95 1.95 2.99 4.62 6.66
0.71 0.71 1.36 2.61 2.91
OME 3.30 2.30 3.45 2.30 3.80 3.60
1.06 0.92 1.46 2.42 2.09 2.53
Data are median values and standard deviations. Total leukocyte count and subtype percentages were assessed by automatic cell counter. CD34+ 
absolute concentration (cells/μL) and percentage were obtained by flow cytometry.Journal of Translational Medicine 2009, 7:91 http://www.translational-medicine.com/content/7/1/91
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lated altitude) or longer hypoxic sessions as these might
not be tolerated by some people or patients.
It is also worth noting some of the advantages of muscular
electrostimulation over exercise during hypoxia exposure:
a) it is easy to measure and reproduce; b) it can be applied
in a hypoxic atmosphere (hypobaric chamber or breath-
ing a hypoxic mixture); and c) it can be applied to the
majority of humans, even those with mild or severe phys-
ical limitations for standard exercise. It is not clear from
the present study whether muscular electrostimulation
should necessarily be applied simultaneously during
hypoxia exposure.
The major limitations of the present study are the short
total duration of the hypoxic stimulus in OHE (which was
sufficient in HME) and the small sample size; however,
given the results it does not seem very likely that a larger
sample size would produce significant differences. The
lack of a more complete hematologic study means we can-
not rule out the possibility that the CD34+ increase is
caused by a decrease in "homing" mechanisms in possible
target tissues, although this does not seem a likely phe-
nomenon in this case.
Regrettably, our protocol is unable to determine the opti-
mal stimulation timing in order to produce a stable
increase in CD34+  cells, although the apparent main-
tained effect observed (CD34+ increasing 7 days after the
stimulus) suggests that some repeated "doses" might
alone be enough.
Further studies are required to address several questions
derived from the present research: a) the potential reper-
cussions of the detected CD34+  increase on different
pathologies, it perhaps being possible to increase HSC
homing in injured tissues because after the release of
HSCs from bone marrow, cells home to ischemic or dam-
aged regions via alterations of the affected tissue [39]; b)
determining the most efficient protocols to induce an
optimal and maintained increase in HSC; c) the possibil-
ity that the OH or OME stimulus applied via more persist-
ent schedules might also induce a measurable increase in
HSC; and d) the need for a more exhaustive study of the
possible subclasses of SC released under HME conditions.
Conclusion
1) A simple protocol stimulating healthy humans with
hypoxia plus muscle electrostimulation can quickly
induce a notable increase in blood HSC.
2) The significant differences obtained in the HME exper-
imental set over such a short period of time, coupled with
the easy application of these two combined stimuli, make
this method an interesting tool to increase efficiency in
peripheral HSC collection.
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